Capnography During Upper GI Endoscopy

Clinical Value of Advanced Patient Monitoring With Capnography and Analysis of the Integrated Pulmonary Index During Interventional Upper Gastrointestinale Endoscopy

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01242345

Enrollment

170

Registered

2010-11-17

Start date

2010-06-30

Completion date

2011-11-30

Last updated

2011-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Capnography as an Adjunct to Standard Monitoring During Midazolam and Propofol Sedation for Interventional Upper GI Endoscopy

Keywords

Hypoxemia, Capnography, Integrated pulmonary index, Sedation, Propofol, Safety

Brief summary

In this randomized controlled trial the utility of capnography and IPI gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.

Interventions

DEVICECapnography

Monitoring of the capnography curve for early detection of apnea

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Age\>=18 * Scheduled for interventional upper GI endoscopy with midazolam and propofol sedation

Exclusion criteria

* No informed consent * ASA IV or V * Emergency endoscopy * Preexisting hypotension, bradycardia or hypoxemia

Design outcomes

Primary

Measure	Time frame
Hypoxemia	From the start to the end of endoscopy, i.e. from 0 h to approximately 2 h

Secondary

Measure	Time frame
Further complications	From the start to the end of endoscopy, i.e. from 0 h to approximately 2 h

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026